Cholesterol inhibitors block lymphatic vessel growth ETH Life Their search for novel pharmaceuticals that might prevent the generation of tumour metastases and transplant rejection identified a well-known drug class: the statins. These cholesterol-lowering compounds are standardly used to treat patients with ... |
